Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Association of DRIL with OCT Outcomes in Uveitic Macular Edema in the POINT study
Author Affiliations & Notes
  • Brandon Vander Zee
    Wisconsin Reading Center, Department of Ophthalmology & Visual Sciences, University of Wisconsin System, Madison, Wisconsin, United States
  • Sam Whittier
    Wisconsin Reading Center, Department of Ophthalmology & Visual Sciences, University of Wisconsin System, Madison, Wisconsin, United States
  • Amitha Domalpally
    Wisconsin Reading Center, Department of Ophthalmology & Visual Sciences, University of Wisconsin System, Madison, Wisconsin, United States
  • Jeong W Pak
    Wisconsin Reading Center, Department of Ophthalmology & Visual Sciences, University of Wisconsin System, Madison, Wisconsin, United States
  • Rick Voland
    Wisconsin Reading Center, Department of Ophthalmology & Visual Sciences, University of Wisconsin System, Madison, Wisconsin, United States
  • Jennifer E Thorne
    Department of Epidemiology, Johns Hopkins Medicine Wilmer Eye Institute, Baltimore, Maryland, United States
    Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Maryland, United States
  • Elizabeth Sugar
    Department of Epidemiology, Johns Hopkins Medicine Wilmer Eye Institute, Baltimore, Maryland, United States
  • Janet Holbrook
    Department of Epidemiology, Johns Hopkins Medicine Wilmer Eye Institute, Baltimore, Maryland, United States
  • Douglas A Jabs
    Department of Epidemiology, Johns Hopkins Medicine Wilmer Eye Institute, Baltimore, Maryland, United States
    Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Maryland, United States
  • Michael Altaweel
    Wisconsin Reading Center, Department of Ophthalmology & Visual Sciences, University of Wisconsin System, Madison, Wisconsin, United States
  • Footnotes
    Commercial Relationships   Brandon Vander Zee None; Sam Whittier None; Amitha Domalpally None; Jeong Pak None; Rick Voland None; Jennifer Thorne Canfield, Gilead, UptoDate, Code C (Consultant/Contractor), NIE, ACTG, Code F (Financial Support), Tarsier, Code O (Owner); Elizabeth Sugar Holbrook grant, Code F (Financial Support); Janet Holbrook None; Douglas Jabs None; Michael Altaweel Opsis therapeutics, Code C (Consultant/Contractor), national eye institute and Aura Biosciences, Code F (Financial Support)
  • Footnotes
    Support  Research to Prevent Blindness. In addition, this study is a multicenter clinic trial supported by collaborative agreements from the National Eye Institute, National Institutes of Health (Dr. Jabs U10EY024526, Dr. Holbrook U10EY024527, Dr. Altaweel U10EY024531). Allergan (Irvine, CA) donated a limited supply of dexamethasone implants for participants who could not obtain them otherwise.
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1381. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Brandon Vander Zee, Sam Whittier, Amitha Domalpally, Jeong W Pak, Rick Voland, Jennifer E Thorne, Elizabeth Sugar, Janet Holbrook, Douglas A Jabs, Michael Altaweel; Association of DRIL with OCT Outcomes in Uveitic Macular Edema in the POINT study. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1381.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine the association of disorganization of the retinal inner layers (DRIL) with optical coherence tomography (OCT) imaging parameters among participants with uveitic macular edema from the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) study.

Methods : The POINT Trial compared the effectiveness of 3 regional corticosteroid injections for uveitic macular edema (UME). Among these participants, OCT scans were evaluated at baseline for the presence of DRIL, along with location with respect to central 1 mm circle. Central subfield thickness (CST), photoreceptor thickness, cysts, subretinal fluid, ellipsoid zone (EZ) status, and choroidal thickness were assessed at baseline. CST percent reduction was compared using baseline and week 12 (primary endpoint) values. Subjects with significant vitreomacular traction or severe epiretinal membranes were excluded. Statistical analysis was conducted with a mixed-effects model using a random effect to account for bilateral study eyes.

Results : Of 231 eyes (190 participants), 191 eyes (83%) had DRIL at baseline. DRIL was seen within central 1mm in 182 eyes (79%). Mean CST at baseline was 375 um (SD 96) in eyes without DRIL and 500 um (SD 143) in eyes with DRIL (p < 0.001). Relative decrease in CST between baseline and week 12 in eyes without DRIL was 16% and with DRIL was 34% (p<0.001). Mean photoreceptor thickness was 31.7 um (SD 4.8) in eyes without DRIL and 28.9 um (SD 7.5) in eyes with DRIL (p = 0.015). In eyes without and with DRIL, EZ disruption within the Central subfield was found in 10.2% of eyes and 26.4%, respectively (p = 0.006). Mean choroidal thickness was 263 um (SD 82) in eyes without DRIL and 252 (SD 80) in eyes with DRIL (p = 0.412). Among other OCT features evaluated, DRIL was significantly associated with cystoid spaces (p< 0.001) but not with subretinal fluid (p = 0.534). Inter-grader agreement provided an 84% exact agreement for the presence of DRIL within the Central subfield.

Conclusions : In the POINT study, a notable prevalence of DRIL was observed in patients with uveitic macular edema, underlining its strong association with increased CST, cystoid spaces, photoreceptor thickness, and EZ disruption. Investigating the evolution of DRIL longitudinally, as the edema subsides, will provide insights in understanding its prognostic value and implications for long-term treatment outcomes.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×